Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Impact Biomedical Inc fell by 1.00k. Cash Flow from Financing totalled 2.87m or -- of revenues. In addition the company used 2.85m for operations while cash used for investing totalled 15.00k.
Cash flow per share | -0.2784 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 2.03 |
---|---|
Tangible book value per share | -1.75 |
More ▼
Balance sheet in USDView more
Current ratio | 0.0212 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.5755 |
---|---|
Total debt/total capital | 0.3377 |
More ▼